A detailed history of Legal & General Group PLC transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Legal & General Group PLC holds 53,540 shares of PRCT stock, worth $4.76 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,540
Previous 53,540 -0.0%
Holding current value
$4.76 Million
Previous $4.29 Million -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$56.31 - $84.99 $216,174 - $326,276
3,839 Added 7.72%
53,540 $4.29 Million
Q2 2024

Aug 14, 2024

BUY
$45.73 - $69.19 $226,272 - $342,352
4,948 Added 11.06%
49,701 $3.04 Million
Q1 2024

May 14, 2024

BUY
$40.38 - $50.75 $47,325 - $59,479
1,172 Added 2.69%
44,753 $2.21 Million
Q4 2023

Feb 15, 2024

BUY
$24.89 - $43.41 $127,287 - $221,998
5,114 Added 13.29%
43,581 $1.83 Million
Q3 2023

Nov 14, 2023

BUY
$30.02 - $38.81 $138,422 - $178,952
4,611 Added 13.62%
38,467 $1.26 Million
Q2 2023

Aug 14, 2023

BUY
$26.7 - $37.02 $715,453 - $991,987
26,796 Added 379.55%
33,856 $1.2 Million
Q1 2023

May 15, 2023

BUY
$26.64 - $39.74 $5,780 - $8,623
217 Added 3.17%
7,060 $200,000
Q4 2022

Feb 14, 2023

BUY
$38.78 - $46.78 $11,440 - $13,800
295 Added 4.51%
6,843 $284,000
Q3 2022

Nov 14, 2022

SELL
$30.9 - $50.65 $84,882 - $139,135
-2,747 Reduced 29.55%
6,548 $271,000
Q2 2022

Aug 22, 2022

BUY
$29.23 - $44.45 $250,939 - $381,603
8,585 Added 1209.15%
9,295 $304,000
Q4 2021

Feb 14, 2022

BUY
$24.6 - $46.29 $17,466 - $32,865
710 New
710 $18,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.97B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.